APA

Pellicer A., Greisen G., Benders M., Claris O., Dempsey E., Fumagalli M., Gluud C., Hagmann C., Hellström-Westas L., Hyttel-Sorensen S., Lemmers P., Naulaers G., Pichler G., Roll C., van Bel F., van Oeveren W., Skoog M., Wolf M. & Austin T. (20140703). The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. : Neonatology.

Chicago

Pellicer Adelina, Greisen Gorm, Benders Manon, Claris Olivier, Dempsey Eugene, Fumagalli Monica, Gluud Christian, Hagmann Cornelia, Hellström-Westas Lena, Hyttel-Sorensen Simon, Lemmers Petra, Naulaers Gunnar, Pichler Gerhard, Roll Claudia, van Bel Frank, van Oeveren Wim, Skoog Maria, Wolf Martin and Austin Topun. 20140703. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. : Neonatology.

Harvard

Pellicer A., Greisen G., Benders M., Claris O., Dempsey E., Fumagalli M., Gluud C., Hagmann C., Hellström-Westas L., Hyttel-Sorensen S., Lemmers P., Naulaers G., Pichler G., Roll C., van Bel F., van Oeveren W., Skoog M., Wolf M. and Austin T. (20140703). The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. : Neonatology.

MLA

Pellicer Adelina, Greisen Gorm, Benders Manon, Claris Olivier, Dempsey Eugene, Fumagalli Monica, Gluud Christian, Hagmann Cornelia, Hellström-Westas Lena, Hyttel-Sorensen Simon, Lemmers Petra, Naulaers Gunnar, Pichler Gerhard, Roll Claudia, van Bel Frank, van Oeveren Wim, Skoog Maria, Wolf Martin and Austin Topun. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. : Neonatology. 20140703.